US2012142660A1PendingUtilityA1
Aminopyrimidines useful as kinase inhibitors
Est. expiryNov 3, 2025(expired)· nominal 20-yr term from priority
Inventors:Hayley BinchMichael MortimoreDamien FraysseChris DavisMichael O'DonnellSimon EverittDaniel RobinsonJoanne PinderAndrew Miller
A61P 35/00A61P 35/02A61P 9/00A61P 37/08A61P 43/00A61P 27/14A61P 29/00A61P 25/28A61P 3/00A61P 19/08C07D 413/12C07D 417/12C07D 403/12C07D 417/14C07D 239/38C07D 403/14C07D 401/14C07D 413/14C07D 239/02A61K 31/4155
59
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to compounds useful as inhibitors of protein kinases. The invention also provides pharmaceutically acceptable compositions comprising those compounds and methods of using the compounds and compositions in the treatment of various disease, conditions, and disorders. The invention also provides processes for preparing compounds of the invention.
Claims
exact text as granted — not AI-modified1 . A compound selected from the following compounds:
2 . A composition comprising a compound of claim 1 and a pharmaceutically acceptable carrier, adjuvant, or vehicle.
3 . A method of treating a proliferative disorder in a patient comprising the step of administering to said patient a compound of claim 1 , wherein the proliferative disorder is colon cancer.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.